Home  >  Research  >  

In Progress

Fungxol®The first paclitaxel bulk fermented by fungus
Internationally, SungenBio is the first to produce paclitaxel bulk from fermented fungal by using fermentation production technology of Genetic Engineering strains"ST026",which is advanced technology of the fourth generation.Fungxol®has gained patents of invention.

This technology belongs to our independent innovation that has already passed appraisal of national authority branch.It is one of the national key breakthrough project(number: 200649841003), and has obtained National Invention Patent(Number: ZL 200410169347.8), International Invention Patent(Public Number: WO 2006/009518 A1), American Invention Patent(Public Number: US 2007/0218531 A1)and European patent:EP1781773.

 

 

Alternol™
In 2009, SungenBio gained the national major anti-cancer drug developmen t project.

A new molecular entity(Weikang Alcohol)fermented by Paclitaxel fungi has prominent effect against cancer and fungal infection,and has applied for national patent. National Invention Patent Number: ZL 2005 10105664.5, International Invention Patent Public Number: WO 2006/036131 A1, American Invention Patent Public Number: US 2009/0203775 A1 and European patent: EP1794142.

 

 

R-hirudin
International ingenious patent of invention technology(pushed by national 3 five-year plan).

In 2003,SungenBio signed the "Genetic Engineering Restructuring of Anticoagulant Drug R-hirudinTM" with the College of Life Sciences at Peking University. We produce Hirudin by Genetic Engineering Restructuring, which has got patent of invention.Patent Number:ZL 031092446.

COPYRIGHT © 2019 Sungen Bioscience Co.,Ltd Technical support: Lanhai Net